MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
MARIMED INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.06−0.00 (-3.39%)
Close on Oct 19, 2026
- Market cap
- $22.78M
- P/E (TTM)
- –
- Dividend yield
- –
MARIMED INC. revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product sales - wholesale | $71.69M | $70.31M | $69.58M | $68.16M | $66.44M | $65.18M | $62.90M | $60.42M | $57.75M | $52.92M | $48.79M | $44.89M | 43.8% | +7.9% |
| Management fees | – | – | – | – | – | – | – | $1.41M | $1.26M | $1.13M | $711.00K | $96.00K | – | – |
| Supply procurement | – | – | – | – | – | – | – | $1.43M | $1.43M | $1.45M | $1.53M | $1.65M | – | – |
| Licensing fees | – | – | – | – | – | – | – | $181.00K | $162.00K | $230.00K | $261.00K | $310.00K | – | – |
| Product sales - retail | – | – | – | – | – | – | – | – | – | – | – | $108.38M | – | – |
By region
From the segment and revenue-disaggregation notes of Marimed's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.